ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,182, issued on Nov. 4, was assigned to CellAxia Inc. (Tokyo).
"Cell-containing pharmaceutical composition" was invented by Takayuki Asahara (Kanagawa, Japan), Amankeldi A. Salybekov (Kanagawa, Japan) and Makoto Seki (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition containing a cell population with enriched M2 macrophage and a pharmaceutically acceptable carrier is provided. The composition is not trapped in the lungs when administered systemically, and accumulates at a disorder/inflammation site. Therefore, the pharmaceutical composition of the present invention is useful as an anti-inflammatory pharmaceutical compos...